UnitedHealth Group OptumRx — Revenue increased by 3.2% to $39.68B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 16.0%, from $34.21B to $39.68B. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates growth in pharmacy benefit management volume, successful contract acquisitions, or expansion in specialty pharmacy services, while a decrease may signal loss of major plan sponsors or pricing pressures.
This metric represents the total gross revenue generated by the pharmacy care services segment, primarily derived from p...
Comparable to pharmacy benefit management (PBM) revenue segments at major health insurers and independent pharmacy services providers.
unh_segment_optum_rx_revenues| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $22.52B | $23.34B | $23.91B | $24.81B | $25.20B | $27.42B | $28.65B | $28.86B | $30.84B | $32.42B | $34.21B | $35.13B | $38.46B | $39.68B |
| QoQ Change | — | +3.6% | +2.5% | +3.7% | +1.6% | +8.8% | +4.5% | +0.7% | +6.9% | +5.1% | +5.5% | +2.7% | +9.5% | +3.2% |
| YoY Change | — | — | — | +10.1% | +8.0% | +14.7% | +15.5% | +14.5% | +12.5% | +13.2% | +18.5% | +13.9% | +18.6% | +16.0% |
We use cookies for analytics. See our Privacy and Cookie Policy.